Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS

Abstract

DN, GP, and thalamus gadolinium deposition in early MS is associated with lifetime cumulative gadodiamide administration without clinical or radiologic correlates of more aggressive disease.